Provided by Tiger Trade Technology Pte. Ltd.

Arrowhead Pharmaceuticals

70.67
-10.0000-12.40%
Pre-market: 71.660.9900+1.40%04:06 EDT
Volume:4.37M
Turnover:321.71M
Market Cap:9.95B
PE:-30.94
High:83.55
Open:82.89
Low:70.61
Close:80.67
52wk High:95.49
52wk Low:28.48
Shares:140.86M
Float Shares:122.00M
Volume Ratio:2.45
T/O Rate:3.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.2838
EPS(LYR):-0.0122
ROE:-55.21%
ROA:-8.10%
PB:21.38
PE(LYR):-5,795.95

Loading ...

Arrowhead Pharmaceuticals Presents Phase 3 Shasta-3 and Shasta-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events in Patients with Severe Hypertriglyceridemia

THOMSON REUTERS
·
Aug 30

Arrowhead Pharma Director Michael S. Perry Disposes of 11,600 Shares for $1.01 Million

Reuters
·
Aug 21

Arrowhead announces availability of REDEMPLO for FCS in Germany

TIPRANKS
·
Aug 17

People Living with Familial Chylomicronaemia Syndrome (Fcs) in Germany Have Access to Redemplo® (Plozasiran) as a New Treatment Option to Reduce Triglycerides

THOMSON REUTERS
·
Aug 17

Arrowhead Pharmaceuticals Earnings Call Signals Confident Expansion

TIPRANKS
·
Aug 16

How Investors Are Reacting To Arrowhead Pharmaceuticals (ARWR) Soaring Sales But Deepening Losses

Simply Wall St.
·
Aug 11

Arrowhead price target raised to $120 from $115 at H.C. Wainwright

TIPRANKS
·
Aug 07

Analysts Are Bullish on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Vera Therapeutics (VERA)

TIPRANKS
·
Aug 05

U.S. Research Roundup-Ametek, Ball Corp, McDonald's

Reuters
·
Aug 05

Arrowhead Pharmaceuticals (ARWR) Gets a Buy from Chardan Capital

TIPRANKS
·
Aug 05

Arrowhead Publishes Transcript of Fiscal 2026 Third-Quarter Conference Call

Reuters
·
Aug 05

Arrowhead Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Arrowhead Pharma Acquires FDA Rare Pediatric Disease Priority Review Voucher

Reuters
·
Aug 05

Earnings Flash (ARWR) Arrowhead Pharmaceuticals Posts Fiscal Q3 Loss $1.36, vs. FactSet Est of $1.28 Loss

MT Newswires Live
·
Aug 05

Arrowhead Pharmaceuticals Q3 Revenue Jumps on Redemplo Growth

Reuters
·
Aug 05

Arrowhead Net Loss Widens to $194.28 Million in FY26 Q3; Revenue Rises to $75.25 Million

Reuters
·
Aug 05

Arrowhead Pharma Q3 EPS $(1.36) Misses $(1.32) Estimate, Sales $75.253M Beat $54.294M Estimate

Benzinga Earnings
·
Aug 05

Arrowhead Pharmaceuticals Reports Fiscal 2026 Third Quarter Results

THOMSON REUTERS
·
Aug 05

Arrowhead Pharmaceuticals Q3 EPS USD -1.36

THOMSON REUTERS
·
Aug 05

Arrowhead Pharmaceuticals Q3 Operating Income USD -170.093 Million

THOMSON REUTERS
·
Aug 05